{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:23Z","timestamp":1792787843771,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong Municipal Science and Technology Project","award":["MS22022020"],"award-info":[{"award-number":["MS22022020"]}]},{"name":"Nantong Municipal Science and Technology Project","award":["MS22022020"],"award-info":[{"award-number":["MS22022020"]}]},{"name":"Nantong Municipal Science and Technology Project","award":["MS22022020"],"award-info":[{"award-number":["MS22022020"]}]},{"name":"Nantong Municipal Science and Technology Project","award":["MS22022020"],"award-info":[{"award-number":["MS22022020"]}]},{"name":"Nantong Municipal Science and Technology Project","award":["MS22022020"],"award-info":[{"award-number":["MS22022020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04264-9","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T07:43:39Z","timestamp":1754898219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema"],"prefix":"10.1186","volume":"25","author":[{"given":"Yao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-qiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-jin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"4264_CR1","doi-asserted-by":"publisher","first-page":"1106706","DOI":"10.3389\/fendo.2023.1106706","volume":"14","author":"LKY Chan","year":"2023","unstructured":"Chan LKY, Lin SS, Chan F, et al. Optimizing treatment for diabetic macular edema during cataract surgery[J]. Front Endocrinol (Lausanne). 2023;14:1106706.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4264_CR2","doi-asserted-by":"crossref","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and Treatments. Int J Mol Sci. 2018;19(6):1816.","DOI":"10.3390\/ijms19061816"},{"issue":"6","key":"4264_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bjo.2005.087403","volume":"90","author":"JI Patel","year":"2006","unstructured":"Patel JI, Hykin PG, Cree IA. Diabetic cataract removal: postoperative progression of maculopathy\u2013growth factor and clinical analysis[J]. Br J Ophthalmol. 2006;90(6):697\u2013701.","journal-title":"Br J Ophthalmol"},{"key":"4264_CR4","first-page":"331","volume":"04","author":"WS Su Shu","year":"2020","unstructured":"Su Shu WS, Wu J, et al. Feasibility and clinical significance of intraoperative real-time fundus examination in cataractous eyes. Chin J Exp Ophthalmol. 2020;04:331\u20135.","journal-title":"Chin J Exp Ophthalmol"},{"issue":"11","key":"4264_CR5","first-page":"850","volume":"57","author":"S Su","year":"2021","unstructured":"Su S, Wu J, Ji M, et al. [A comparative study of three intraoperative real-time fundus examinations in cataractous eyes][J]. Zhonghua Yan Ke Za Zhi. 2021;57(11):850\u20136.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"4264_CR6","doi-asserted-by":"publisher","first-page":"159436","DOI":"10.1155\/2011\/159436","volume":"2011","author":"P Udaondo","year":"2011","unstructured":"Udaondo P, Garcia-Pous M, Garcia-Delpech S, et al. Prophylaxis of macular edema with intravitreal Ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study[J]. J Ophthalmol. 2011;2011:159436.","journal-title":"J Ophthalmol"},{"key":"4264_CR7","doi-asserted-by":"publisher","first-page":"2648267","DOI":"10.1155\/2019\/2648267","volume":"2019","author":"LQ Zhao","year":"2019","unstructured":"Zhao LQ, Cheng JW. A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy. J Ophthalmol. 2019;2019:2648267.","journal-title":"J Ophthalmol"},{"key":"4264_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajo.2021.04.002","volume":"229","author":"MR Starr","year":"2021","unstructured":"Starr MR, Mahr MA, Smith WM, et al. Outcomes of patients with active diabetic macular edema at the time of cataract surgery managed with intravitreal Anti-Vascular endothelial growth factor Injections[J]. Am J Ophthalmol. 2021;229:194\u20139.","journal-title":"Am J Ophthalmol"},{"key":"4264_CR9","doi-asserted-by":"publisher","first-page":"6928524","DOI":"10.1155\/2019\/6928524","volume":"2019","author":"J Wu","year":"2019","unstructured":"Wu J, Zhong Y, Yue S, et al. Aqueous Humor Mediator and Cytokine Aberrations in Diabetic Retinopathy and Diabetic Macular Edema: A Systematic Review and Meta-Analysis. Dis Markers. 2019;2019:6928524.","journal-title":"Dis Markers"},{"issue":"10","key":"4264_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr., et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema[J]. Ophthalmology. 2014;121(10):1904\u201314.","journal-title":"Ophthalmology"},{"issue":"4","key":"4264_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European society of retina specialists (EURETINA)[J]. Ophthalmologica. 2017;237(4):185\u2013222.","journal-title":"Ophthalmologica"},{"key":"4264_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajo.2022.01.004","volume":"238","author":"DM Brown","year":"2022","unstructured":"Brown DM, Emanuelli A, Bandello F, et al. KESTREL and KITE: 52-Week results from two phase III pivotal trials of Brolucizumab for diabetic macular Edema[J]. Am J Ophthalmol. 2022;238:157\u201372.","journal-title":"Am J Ophthalmol"},{"key":"4264_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2023.07.012","volume":"260","author":"CC Wykoff","year":"2024","unstructured":"Wykoff CC, Garweg JG, Regillo C, et al. KESTREL and KITE phase 3 studies: 100-Week results with Brolucizumab in patients with diabetic macular Edema[J]. Am J Ophthalmol. 2024;260:70\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4264_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","volume":"126","author":"PA Campochiaro","year":"2019","unstructured":"Campochiaro PA, Marcus DM, Awh CC, et al. The Port delivery system with Ranibizumab for neovascular Age-Related macular degeneration: results from the randomized phase 2 ladder clinical Trial[J]. Ophthalmology. 2019;126(8):1141\u201354.","journal-title":"Ophthalmology"},{"key":"4264_CR15","doi-asserted-by":"crossref","unstructured":"Yang X, Cao Y, Cao X, et al. Anti-VEGF monotherapy versus anti-VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A bayesian network meta-analysis. Diabetes Obes Metab. 2025;(5):2679\u201389.","DOI":"10.1111\/dom.16270"},{"issue":"6","key":"4264_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"JA Wells","year":"2016","unstructured":"Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or Ranibizumab for diabetic macular edema: Two-Year results from a comparative effectiveness randomized clinical Trial[J]. Ophthalmology. 2016;123(6):1351\u20139.","journal-title":"Ophthalmology"},{"key":"4264_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40942-015-0005-8","volume":"1","author":"TE de Carlo","year":"2015","unstructured":"de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA)[J]. Int J Retina Vitreous. 2015;1:5.","journal-title":"Int J Retina Vitreous"},{"issue":"3","key":"4264_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/CH-221634","volume":"83","author":"AG Koutsiaris","year":"2023","unstructured":"Koutsiaris AG, Batis V, Liakopoulou G, et al. Optical coherence tomography angiography (OCTA) of the eye: A review on basic principles, advantages, disadvantages and device specifications[J]. Clin Hemorheol Microcirc. 2023;83(3):247\u201371.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"5","key":"4264_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS. Inflammation in diabetic retinopathy[J]. Prog Retin Eye Res. 2011;30(5):343\u201358.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4264_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41433-023-02667-w","volume":"38","author":"C Rennie","year":"2024","unstructured":"Rennie C, Lotery A, Payne J, et al. Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in Phakic patients[J]. Eye (Lond). 2024;38(1):215\u201323.","journal-title":"Eye (Lond)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04264-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:13:44Z","timestamp":1757362424000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04264-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4264"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04264-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6171645\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Affiliated Hospital of Nantong University. The trial registration number is 2019-K068.Informed consent was obtained from all participating subjects after they were given an explanation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}